“…Release factors RF1 and RF2 were purified from wild-type strains (Tate & Caskey, 1990) or from release factor overexpressing strains (Adamski et al+, 1994)+ RF3 was purified as described (Grentzmann et al+, 1994) by HPLC on DEAE (Waters)+ Contamination by elongation factors was efficiently eliminated by a supplementary step on CM-Sephadex (Pharmacia) Grentzmann et al+, 1994)+ Release factor fractions were checked for GTP contamination using electrospray mass spectrometry (Crain, 1990;Straub & Voyksner, 1993)+ Concentrations of purified release factor fractions in terms of amount of protein per unit of volume was not constant compared to the number of molecules of active protein per unit of volume+ For example, overexpression of release factors has been shown to result in loss of specific activity (Adamski et al+, 1994) and a possible site for posttranslational modification for RF2 has been reported (Uno et al+, 1996)+ We therefore estimated the quantities of active release factors in units of activity as described previously (Caskey et al+, 1971;Grentzmann et al+, 1994)+ tRNAfmet (Subriden) was charged and purified according to Tate and Caskey (1990)+ Tight couple ribosomes were purified as described (Spedding, 1990)+ UUC AUG UAA, UUC AUG UAG, and UUC AUG UGA RNA oligonucleotides were synthesized on an ABI synthesizer, deprotected, and purified on Sephadex G-25 (Pharmacia)+ Sequences were verified by mass spectroscopy (Limbach et al+, 1995)+ RRF was purified from an overexpressing strain (Ichikawa & Kaji, 1989) as described (Hirashima & Kaji, 1972)+ EF-G was purified and its activity was tested as described (Kaziro et al+, 1972)+…”